Buccal fentanyl may be valid option during placement of indwelling central venous access port
the ONA take:
Fentanyl buccal tablet is a valid, practical, and safe method of procedural analgesia for patients with cancer during placement of indwelling central venous access systems, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.
Although local anesthesia is most commonly used to overcome pain related to the procedural placement of fully implantable venous access systems in patients with cancer, it may not eradicate all pain. Therefore, researchers sought to evaluate the effectiveness and safety of fentanyl buccal tablet in reducing procedural pain related to the placement of the port in opioid-naïve patients.
For the study, researchers enrolled 65 inpatients who required an indwelling vascular access port. Patients received a 100-mcg fentanyl buccal tablet 10 minutes before preparation of the operating field.
Results showed that nearly 94% of patients experienced no or little pain during the procedure. Only four patients reported a lot of pain, and no patients reported very severe pain.
In regard to safety, 43.1% experienced drowsiness, 9.2% experienced nausea, and 4.7% experienced vomiting, at the end of the procedure. Four hours after the procedure, the rates of drowsiness, nausea, and vomiting were 12.5%, 10.9%, and 7.8%, respectively.
“It will be necessary to perform further studies, taking into account the need for standard antiemetic premedication to [minimize] the incidence of nausea and vomiting,” the authors conclude.
Fentanyl buccal tablet is a valid, practical, and safe method of procedural analgesia for patients with cancer.
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Including a PI3-Kinase Inhibitor with an PARP Inhibitor Improves Tumor Shrinkage in Patients with Resistant Ovarian Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
- PSA Screening Rates Level Off in United States
- CQGS Releases Standards for Surgical Care of Older Adults
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|